AMGEN Inc. Live Share Price Today, Share Analysis and Chart
about
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...
Read More282.56 4.16 (1.49%)
1.8M XNAS Volume
XNAS 29 May, 2025 2:52 PM (EDT)
Board Meeting
The next board meeting for AMGEN Inc. is on 30 May 2025 for the purpose of Amgen Inc Annual General Meeting for 2025
See details
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
AMGEN Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..